LOUISVILLE, KY., March 2, 2016 -- Appriss Inc., a leading technology provider for risk assessment and analytics in public safety and health care, announced that is has signed an agreement with Marshfield Clinic and facilitate easy integration of opiate prescription histories into electronic medical records (EMRs). The Appriss integration solution provides opiate prescription histories in real-time, at the point-of-care. This increased accessibility is expected to increase prescription monitoring data usage to improve patient safety and combat prescription drug abuse and diversion.
The Appriss secure integration technology provides a variety of options for health IT systems to integrate Prescription Monitoring Program (PMP) data into physician and pharmacist workflows. Physicians and pharmacists currently log into separate websites to retrieve a patient's opiate prescriptions and then cross-reference this data with a patient's health information in other systems. At Marshfield Clinic, the Appriss integration provides instant access to the patient's data within the electronic health records.
"Our Marshfield Clinic physicians have overwhelmingly embraced Appriss' mission of improving prescribing confidence," said Dr. Eric Penniman, East District 4 Medical Director for Primary Care. "Having access to prescription monitoring data directly from within the medication prescribing program has been significant for our physicians and they are universally grateful for this EMR tool."
The benefits of EHR integration and interoperability have long been recognized by Brandeis University's PDMP Center of Excellence (COE). The September 2012 Guidance of PDMP Best Practices recognizes that "integrating PDMP data retrieval with health information exchanges (HIE), electronic health records (EHR), and pharmacy dispensing systems should help reduce the time and effort needed for prescribers and their staff and for pharmacists to access a patient's prescription history." (http://www.pdmpexcellence.org/). The report further details that integration will maximize both the number of users (prescribers and dispensers) receiving the information and the utility for each of those users.
"By providing prescription monitoring data directly at the point-of-care, Marshfield has taken a major step towards improving patient safety in Wisconsin," said Ken Cassell, Vice President of Business Development at Appriss. "Real-time monitoring also saves valuable minutes for providers, helping to ensure the best standard of care for all patients."
For more information about Appriss integration technologies, please visit http://www.appriss.com/pmpgateway.html and http://www.appriss.com/narxcheck.html.
About Appriss
Appriss provides data-driven solutions to fulfill our mission of keeping communities safe and informed. Partnering with public safety, healthcare, and leading private and public companies, Appriss delivers solutions that prevent fraud, mitigate risk, fight crime, ensure compliance, increase public safety and save lives. Appriss' solutions are always backed by excellent customer support with technical agents in the US that are available to help 24x7x365.
For more information, visit www.appriss.com (http://www.appriss.com).
CONTACT: Kathy Sue Bennett
Marketing Manager
Appriss, Inc.
[email protected]


Samsung Boosts DRAM Supply to Tesla as AI-Driven Memory Demand Surges
Meta Expands AI Training With Employee Activity Tracking Tools
Kakaku.com Stock Surges on EQT Takeover Interest Amid Rising Japan Deal Activity
Florida Investigates OpenAI and ChatGPT Over Alleged Role in FSU Shooting
Microsoft Commits $18 Billion to Expand AI and Cloud Infrastructure in Australia
Mercedes-Benz Faces Rising Competition in China but Rejects Price War Strategy
U.S. Raises Alarm Over Chinese AI Firms’ Alleged IP Theft Through Model Distillation
Nvidia Pushes 800V Data Center Power Systems to Boost Efficiency and Cut Costs
Hyundai Plans 20 New Models in China to Boost EV Strategy and Market Share
Why Global Web3 Projects Can't Afford to Skip South Korea: TokenPost Unveils Data-Driven Entry Solutions
Daiichi Sankyo Stock Drops After Earnings Delay and Oncology Review
LG Innotek Stock Hits Record High on $68M Automotive Wi-Fi 7 Deal
SpaceX Eyes $60B Cursor Deal to Boost AI Power Ahead of IPO
Organon Stock Surges After Reports of $13 Billion Buyout Bid by Sun Pharma
Rising Jet Fuel Costs from Iran Conflict Push Airfare Higher Across Europe
SpaceX President Gwynne Shotwell Earns $85.8M as IPO Buzz Grows
Judge Dismisses Elon Musk’s Fraud Claims Against OpenAI, Trial to Proceed on Remaining Allegations 



